|
Negative hyperselection for mutations associated with anti-EGFR antibody resistance in RAS wildtype metastatic colorectal cancer (mCRC): Evaluation of the PANAMA trial (AIO-KRK-0212, maintenance therapy with 5-FU, folinic acid (FU/FA) with or without panitumumab). |
|
|
No Relationships to Disclose |
|
|
Honoraria - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Incyte; Lilly; Merck Serono; Merck Sharp & Dohme; Onkowissen; Pierre Fabre; Sanofi; SERVIER; Taiho Pharmaceutical |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Cor2Ed; Incyte; IQvia; Lilly; Merck Serono; Merck Sharp & Dohme; Onkowissen; Pierre Fabre; Roche; SERVIER |
Research Funding - Amgen (Inst); Servier (Inst) |
Travel, Accommodations, Expenses - Amgen; Merck Serono; SERVIER |
|
|
|
Consulting or Advisory Role - Amgen |
Travel, Accommodations, Expenses - Amgen |
|
|
Stock and Other Ownership Interests - BioNTech |
|
|
Consulting or Advisory Role - Amgen |
Travel, Accommodations, Expenses - Amgen |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Biontech |
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Fujifilm; MSD Oncology; Novartis; Sanofi Aventis GmbH |
Consulting or Advisory Role - Amgen; MSD Oncology |
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim; GlaxoSmithKline; Merck KGaA |
|
Ludwig Fischer Von Weikersthal |
Honoraria - Lilly; Novartis; Pierre Fabre |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; MSD Oncology; Pfizer; Roche Pharma AG; Sanofi; SERVIER |
Travel, Accommodations, Expenses - SERVIER |
|
|
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; MCI Group; Merck Serono; MSD; Roche |
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD; Pierre Fabre; Roche |
Research Funding - AIO-Studien (Inst); Alexion Pharmaceuticals (Inst); Amgen (Inst); AstraZeneca (Inst); BioNTech (Inst); Celgene (Inst); ERYTECH Pharma (Inst); Ipsen (Inst); Lilly (Inst); Rafael Pharmaceuticals (Inst); Roche (Inst); Servier (Inst) |
Travel, Accommodations, Expenses - Roche |
|
|
Employment - University Hospital Essen (I) |
Honoraria - Amgen; Amgen; AstraZeneca; Bristol-Myers Squibb; Lilly; Merck Serono; MSD Oncology; Novartis; Pierre Fabre; Roche; Sanofi/Aventis; SERVIER |
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Janssen-Cilag; Lilly; Merck Serono; MSD Oncology; Novartis; Pierre Fabre; Roche; Sanofi; SERVIER |
Research Funding - Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; Roche/Genentech; SERVIER |
Travel, Accommodations, Expenses - Amgen; BMS; Lilly; Merck Serono; Pierre Fabre; Roche; Sanofi |
Other Relationship - Amgen; Bristol-Myers Squibb; Lilly; Merck Serono; Roche; Sanofi |
|
|
|
Travel, Accommodations, Expenses - Medac; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Amgen; AstraZeneca; Merck; Pfizer; Pierre Fabre; Roche; Sanofi; SERVIER; Sirtex Medical |
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Merck; MSD; MSD Oncology; Novartis; Pierre Fabre; Roche; Sanofi; Sirtex Medical; TERUMO |
Research Funding - Amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Merck (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Servier (Inst); Sirtex Medical (Inst) |
Travel, Accommodations, Expenses - Amgen; Bayer; Merck; Roche; SERVIER; Sirtex Medical |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Amgen; Bayer; LEO Pharma; Lilly; Merck KGaA; MSD; Pierre Fabre; Roche; Sanofi; SERVIER; Taiho Pharmaceutical; Takeda |
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Lilly; Merck KGaA; MSD; Pierre Fabre; Roche; Sanofi; Sanofi; SERVIER; Takeda |
Research Funding - Merck Serono (Inst); Pierre Fabre (Inst); Roche Molecular Diagnostics (Inst) |
Travel, Accommodations, Expenses - Amgen; Bayer; Lilly; Merck KGaA; Pierre Fabre; Roche; Sanofi; Sirtex Medical; Takeda |
|
|
Research Funding - Amgen (Inst) |
Travel, Accommodations, Expenses - Abbvie (Inst); Amgen (Inst); Ipsen (Inst); Johnson & Johnson/Janssen (Inst); MSD (Inst); Novartis (Inst); OMT (Inst); Sanofi/Aventis (Inst); Takeda (Inst) |
|
|
Honoraria - Roche; SERVIER; Taiho Pharmaceutical |
Travel, Accommodations, Expenses - Amgen; Lilly; Pfizer; Roche |